Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis.
Ontology highlight
ABSTRACT: Systemic juvenile idiopathic arthritis (sJIA) is a serious multifactorial autoinflammatory disease with a significant mortality rate due to macrophage activation syndrome (MAS). Recent research has deepened the knowledge about the pathophysiological mechanisms of sJIA-MAS, facilitating new targeted treatments, and biological disease-modifying antirheumatic drugs (bDMARDs), which significantly changed the course of the disease and prognosis. This review highlights that children are less likely to suffer severe COVID-19 infection, but at approximately 2-4 weeks, some cases of multisystem inflammatory syndrome in children (MIS-C) have been reported, with a fulminant course. Previous established treatments for cytokine storm syndrome (CSS) have guided COVID-19 therapeutics. sJIA-MAS is differe
SUBMITTER: Ailioaie LM
PROVIDER: S-EPMC9029451 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA